Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Deviation Handling in Creams Production

Posted on By

SOP for Deviation Handling in Creams Production

Standard Operating Procedure for Deviation Handling in Creams Production

1) Purpose

The purpose of this SOP is to establish a systematic approach for identifying, documenting, investigating, and resolving deviations in creams production to ensure product quality, safety, and regulatory compliance.

2) Scope

This SOP applies to all personnel involved in creams production, including manufacturing, quality control, and quality assurance. It covers all deviations from established procedures, specifications, and regulatory requirements.

3) Responsibilities

The Quality Assurance (QA) Manager is responsible for overseeing the deviation handling process. All personnel are responsible for reporting deviations immediately and cooperating with investigations and corrective actions.

4) Procedure

4.1 Identification and Reporting of Deviations

4.1.1 Identify any deviation from established procedures, specifications, or regulatory requirements during creams production.

See also  SOP for Preventing Contamination in Creams Production

4.1.2 Report the deviation immediately to the supervisor or QA department.

4.1.3 Document the deviation using the Deviation Report Form, including the following information:

  • Date and time of the deviation
  • Description of the deviation
  • Location of the deviation
  • Personnel involved
  • Immediate actions taken

4.2 Deviation Classification

4.2.1 Classify the deviation based on its potential impact on product quality, safety, and regulatory compliance:

  • Minor Deviation: No significant impact on product quality or safety, and no regulatory impact.
  • Major Deviation: Potential impact on product quality or safety, but no significant regulatory impact.
  • Critical Deviation: Significant
impact on product quality, safety, or regulatory compliance.

4.3 Investigation of Deviations

4.3.1 Assign a deviation investigation team led by QA to investigate the root cause of the deviation.

4.3.2 Collect and review all relevant data, including batch records, equipment logs, and personnel statements.

4.3.3 Use root cause analysis tools, such as the 5 Whys or Fishbone Diagram, to determine the underlying cause of the deviation.

4.3.4 Document the findings of the investigation in the Deviation Report.

4.4 Corrective and Preventive Actions (CAPA)

4.4.1 Develop corrective actions to address the immediate cause of the deviation.

4.4.2 Develop preventive actions to eliminate the root cause and prevent recurrence of the deviation.

4.4.3 Assign responsibilities and timelines for implementing CAPA.

4.4.4 Document all CAPA activities in the Deviation Report.

4.5 Deviation Review and Approval

4.5.1 Review the completed Deviation Report and CAPA plan with the QA Manager and other relevant departments.

4.5.2 Obtain approval for the Deviation Report and CAPA plan from QA and other relevant stakeholders.

4.6 Implementation and Follow-Up

4.6.1 Implement the approved corrective and preventive actions according to the assigned timelines.

4.6.2 Monitor the effectiveness of CAPA to ensure that the deviation does not recur.

4.6.3 Conduct follow-up reviews to confirm the successful implementation of CAPA.

4.7 Documentation and Records

4.7.1 Maintain all records related to deviation handling, including Deviation Reports, investigation findings, and CAPA documentation.

4.7.2 Ensure that all deviation records are retained according to the company’s document retention policy.

5) Abbreviations, if any

QA: Quality Assurance

CAPA: Corrective and Preventive Actions

SOP: Standard Operating Procedure

6) Documents, if any

Deviation Report Form

Root Cause Analysis Tools (e.g., 5 Whys, Fishbone Diagram)

CAPA Records

7) Reference, if any

ICH Q10: Pharmaceutical Quality System

FDA Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations

8) SOP Version

Version 1.0

See also  SOP for Change Control in Creams Production
Creams Tags:Analytical method development for creams, Calibration of cream equipment, Cleaning equipment for creams, Cream homogenization SOP, Cream preparation SOP, Documentation for cream production, Emulsification in creams, Final product inspection for creams, Formulation development for creams, In-process testing for creams, Labeling SOP for creams, Maintaining sterility in creams, Microbial testing in creams, Oil-in-water cream formulation, Packaging SOP for creams, Particle size analysis in creams, pH testing of creams, Pharmaceutical cream manufacturing, Preventing contamination in creams, Process optimization for creams, Process validation for creams, Quality control of creams, Raw material inspection for creams, Rheological testing for creams, Stability testing of creams, Storage conditions for creams, Training SOP for cream production, Viscosity testing for creams, Waste disposal in cream production, Water-in-oil cream process

Post navigation

Previous Post: SOP for Process Validation Protocols for Creams
Next Post: SOP for Out of Specification (OOS) Handling in Creams Production

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version